Epizyme Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,483.00
55,005.00
132,376.00
110,212.00
134,309.00
123,630
Depreciation, Depletion & Amortization
703.00
742.00
1,419.00
1,589.00
1,639.00
1,052
Other Funds
79,670.00
286.00
-
-
-
10,448
Funds from Operations
39.00
47,397.00
81,081.00
98,106.00
121,342.00
111,946
Changes in Working Capital
53,773.00
12,034.00
8,156.00
1,629.00
909.00
9,654
Net Operating Cash Flow
53,734.00
35,363.00
72,925.00
96,477.00
120,433.00
121,600
Capital Expenditures
630.00
2,216.00
183.00
624.00
984.00
Purchase/Sale of Investments
-
-
-
164,790.00
114,314.00
Net Investing Cash Flow
630.00
2,216.00
40,183.00
165,414.00
113,330.00
Issuance/Reduction of Debt, Net
-
-
441.00
561.00
620.00
Net Financing Cash Flow
79,947.00
104,110.00
131,336.00
131,357.00
155,872.00
Net Change in Cash
25,583.00
66,531.00
18,228.00
130,534.00
148,769.00
Free Cash Flow
54,364.00
37,579.00
73,108.00
97,101.00
121,417.00
Deferred Taxes & Investment Tax Credit
-
-
-
-
368.00
184
Change in Capital Stock
277.00
103,824.00
131,777.00
131,918.00
156,492.00
Other Uses
-
-
40,000.00
-
-
About Epizyme
View Profile
